Journal List > Korean J Clin Microbiol > v.15(4) > 1038257

Yum, Shin, Yong, and Chong: Diversity of Integrons Carrying blaVIM-2 Cassette in Pseudomonas spp. and Acinetobacter spp.

Abstract

Background

Metallo-β-lactamase-mediated carbapenem resistance has been increasingly reported in Pseudomonas, Acinetobacter and other Gram-negative bacilli (GNB) in many countries. A few studies showed highly variable structure of MBL-gene cassette-carrying integrons. The aim of this study was to determine the structure of blaVIM-2-carrying integrons in Pseudomonas and Acinetobacter.

Methods

blaVIM-2-carrying GNB were isolated at a Korean hospitals during the years 1995-1999 and 2005. The size of blaVIM-2-carrying integrons was estimated by the PCR products. Representative integrons were sequenced by the dideoxy-chain termination method. The MICs of antimicrobial agents were tested by the CLSI agar dilution methods.

Results

During the years 1995-1999 and 2005, the approximate size of the blaVIM-2-carrying class 1 integrons was 3-7 kb in 35 Pseudomonas isolates and 3-5 kb in 24 Acinetobacter isolates. The integrons carried one-five resistance gene cassettes in addition to the blaVIM-2 cassette. Other resistance gene cassettes found were blaOXA-1, aacA1, aac(6')-I, and aac(6')-II. Interestingly, sequences homologous to part of a putative class II intron were inserted into the recombination site of the last cassette in four of nine integrons. The class 1 integron from P. aeruginosa isolates had fused orf/IntI1 in a downstream leftward inverted repeat (IRi).

Conclusion

According to period, the size and structure of blaVIM-2-carrying integrons are quite variable, but an identical one is also present in a different genus, indicating high mobility of the blaVIM-2 cassette and horizontal transfer of the whole integron. We suggest that the class 1 integron containing the blaVIM-2 gene is spreading horizontally among Gram-negative bacilli and is undergoing continuous development in Korea.

Figures and Tables

Fig. 1
Comparison of the structures of variable regions of class 1 integrons determined in this study. Hatched rectangles indicate the 5'- and 3'-conserved segments (5'-CS and 3'-CS), black arrows the cassette-borne resistance genes, empty rectangles the attC sites of the cassettes, small rectangle the IRi sites of the integron, and gray circles the recombination core sites and inverse core sites. The insertion and orientation of part of putative class II intron in the recombination site of the last cassette of In106 and integron in P. putida YMC 99/10/431, P. aeruginosa YMC 95/1/704, and P. aeruginosa YMC 05/5/1103 are indicated.
kjcm-15-131-g001
Fig. 2
Deduced amino acid changes of aac(6')-I detected in this study, compared to aac(6')-I deduced amino acid reported by Nobuta et al. [10], P. aeruginosa YMC 95/1/2105 and P. putida YMC 99/10/431 had a mutation T269C and deduced amino acid change of L90S. P. aeruginosa YMC 95/1/2105 also had G298A and T512A mutations, resulting in amino acid changes of G100S and V171D. Isolates with mutations in this study: Study No. 3, 6 in Table 2. P. aeruginosa YMC 95/1/704 and P. putida YMC 99/10/431; No. 2. Acinetobacter genomospecies 3 YMC 99/11/U160; No. 4. P. aeruginosa YMC 95/1/2105.
kjcm-15-131-g002
Table 1
Charteristics of P. aeruginosa, P. putida and Acinetoabcter isolates with blaVIM-2 carrying integrons
kjcm-15-131-i001

Abbreviations: STR, streptomycin; SPT, spectinomycin; KAN, kanamycin; AMK, amikacin; GEN, gentamicin; ISP, isepamicin; NET, netilmicin; TOB, tobramycin; S, susceptible; I, intermediate; R, resistant; NT, not tested because probably due to presence of the gene in other genetic elements.

Table 2
MIC of antimicrobial agents for blaVIM-2-positive gram-negative bacilli with different position of blaVIM-2 cassette in class 1 integrons
kjcm-15-131-i002

Abbreviations: PIP, piperacillin; CTX, cefotaxime; CAZ, ceftazidime; ATM, aztreonam; IPM, imipenem; MEM, meropenem.

Table 3
Amino acid substitutions in aac(6')-I type aminoglycoside modifying enzymes
kjcm-15-131-i003

Abbreiations: Leu, leucine; Gly, glycine; Val, valine; Ser, serine; Asp, asparagine.

References

1. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011. 55:4943–4960.
2. Lee K, Yong D, Choi YS, Yum JH, Kim JM, Woodford N, et al. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Int J Antimicrob Agents. 2007. 29:201–206.
3. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, et al. Novel acquired metallo-beta-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother. 2005. 49:4485–4491.
4. Pallecchi L, Riccio ML, Docquier JD, Fontana R, Rossolini GM. Molecular heterogeneity of blaVIM-2-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-beta-lactamase. FEMS Microbiol Lett. 2001. 195:145–150.
5. Hall RM, Collis CM. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol Microbiol. 1995. 15:593–600.
6. Riccio ML, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R, et al. Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother. 2000. 44:1229–1235.
7. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000. 44:891–897.
8. Lee K. Trend of bacterial resistance for the past 50 years in Korea and future perspectives-Gram-negative bacteria. Infect Chemother. 2011. 43:458–467.
9. Clinical and Laboratory Standards Institute. Document M100-S15. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. 2005. Wayne, PA: Clinical and Laboratory Standards Institute.
10. Nobuta K, Tolmasky ME, Crosa LM, Crosa JH. Sequencing and expression of the 6'-N-acetyltransferase gene of transposon Tn1331 from Klebsiella pneumoniae. J Bacteriol. 1988. 170:3769–3773.
11. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005. 18:306–325.
12. Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs. 2008. 17:131–143.
13. Poirel L, Rodríguez-Martínez JM, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P. Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands. Antimicrob Agents Chemother. 2010. 54:2420–2424.
14. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009. 53:5046–5054.
15. Sekiguchi J, Morita K, Kitao T, Watanabe N, Okazaki M, Miyoshi-Akiyama T, et al. KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate. Antimicrob Agents Chemother. 2008. 52:4194–4197.
16. Yum JH, Yi K, Lee H, Yong D, Lee K, Kim JM, et al. Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes. J Antimicrob Chemother. 2002. 49:837–840.
17. Yum JH, Yong D, Lee K, Kim HS, Chong Y. A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate. Diagn Microbiol Infect Dis. 2002. 42:217–219.
18. Jeong SH, Lee K, Chong Y, Yum JH, Lee SH, Choi HJ, et al. Characterization of a new integron containing VIM-2, a metallo-beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J Antimicrob Chemother. 2003. 51:397–400.
19. Lee K, Lim JB, Yum JH, Yong D, Chong Y, Kim JM, et al. blaVIM-2 cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother. 2002. 46:1053–1058.
20. Levesque C, Roy PH. Persing DH, Smith TF, editors. PCR Analysis of Integrons. Diagnostic Molecular Microbiology: Principles and Applications. 1993. Washington, DC: American Society for Microbiology;590–594.
21. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother. 1999. 43:727–737.
22. Walsh TR, Toleman MA, Hryniewicz W, Bennett PM, Jones RN. Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother. 2003. 52:116–119.
23. Poirel L, Lambert T, Türkoglü S, Ronco E, Gaillard J, Nordmann P. Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the blaVIM-2 carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob Agents Chemother. 2001. 45:546–552.
24. Lee H, Yong D, Yum JH, Roh KH, Lee K, Yamane K, et al. Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea. Diagn Microbiol Infect Dis. 2006. 56:305–312.
TOOLS
Similar articles